Heart HealthDiabetes & Blood SugarGeneral Health & Wellness
Advanced Cardiovascular, Inflammation & Diabetes Risk
What is Advanced Cardiovascular, Inflammation & Diabetes Risk and why is it important?
This Extended Lipid Panel quantifies the components of a typical
lipid panel (TC, HDL-C and TG) along with ApoB by nuclear magnetic
resonance (NMR) spectroscopy. Results can be used to assist in CVD
risk assessment. GlycA is a composite biomarker that integrates
protein levels and glycosylation states of several acute-phase
proteins, offering a stable measure of systemic inflammation. The
Diabetes Risk Index (DRI) is a nuclear magnetic resonance
spectroscopy (NMR)-derived multimarker score that predicts a
patient's risk of developing type 2 diabetes mellitus (T2D)
independent of glycemic status. DRI derives its performance from
the weighted addition of the Lipoprotein Insulin Resistance Index
(LP-IR) scores with simultaneously-measured levels of
branched-chain amino acids (BCAA).
When to consider Advanced Cardiovascular, Inflammation & Diabetes Risk?
- If you have a family history of early heart disease, stroke, or diabetes.
- If you are managing conditions like high blood pressure, high cholesterol, or insulin resistance.
- When you want to understand if chronic inflammation is contributing to your health concerns.
- If you are overweight, have an unhealthy diet, or lead a sedentary lifestyle, and want to assess your metabolic risk.
- As part of a proactive wellness strategy to gain deeper insights into your long-term health risks.
Who benefits from Advanced Cardiovascular, Inflammation & Diabetes Risk?
- Individuals seeking a comprehensive assessment of their cardiovascular risk beyond traditional cholesterol numbers.
- Those interested in understanding their body's inflammation status as it relates to long-term health.
- People with a family history of heart disease, stroke, or diabetes.
- Anyone wanting to evaluate their personal risk for developing type 2 diabetes, even if their current blood sugar levels are normal or in the prediabetes range.
- Individuals looking to monitor the effectiveness of lifestyle changes or treatments aimed at improving metabolic and cardiovascular health.
When is the Advanced Cardiovascular, Inflammation & Diabetes Risk used?
This advanced panel is a crucial tool for healthcare providers to assess and manage various interconnected health conditions. It is commonly used for:
- Understanding and stratifying the risk of Cardiovascular Diseases (CVD), including atherosclerosis, heart attack, and stroke, by evaluating comprehensive lipid profiles and Apolipoprotein B.
- Identifying and monitoring chronic systemic inflammation, which is often a silent contributor to various diseases and overall health decline.
- Assessing an individual's predisposition and current risk for developing Type 2 Diabetes Mellitus, offering insights beyond standard glucose metrics.
- Evaluating metabolic health status and identifying signs of insulin resistance or metabolic syndrome.
- Guiding lifestyle interventions and treatment strategies for patients with dyslipidemia or those at risk for metabolic and cardiovascular complications.
Important Considerations
It's important to remember that this test provides valuable information, but it should always be interpreted in the context of your overall health history, lifestyle, and other diagnostic findings by a qualified healthcare provider. Factors like recent illness, injury, or inflammation can influence results, especially for GlycA. This test is a tool to help you and your doctor make informed decisions about your health, not a standalone diagnosis.